Correlation Between Black Diamond and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Black Diamond and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Apellis Pharmaceuticals.
Diversification Opportunities for Black Diamond and Apellis Pharmaceuticals
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Black and Apellis is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Black Diamond i.e., Black Diamond and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Black Diamond and Apellis Pharmaceuticals
Given the investment horizon of 90 days Black Diamond Therapeutics is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Black Diamond is 1.11 times more volatile than Apellis Pharmaceuticals. It trades about -0.22 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.14 per unit of volatility. If you would invest 2,698 in Apellis Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 301.50 from holding Apellis Pharmaceuticals or generate 11.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 95.65% |
| Values | Daily Returns |
Black Diamond Therapeutics vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Black Diamond Therap |
| Apellis Pharmaceuticals |
Black Diamond and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Black Diamond and Apellis Pharmaceuticals
The main advantage of trading using opposite Black Diamond and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Black Diamond vs. Lyra Therapeutics | Black Diamond vs. Hookipa Pharma | Black Diamond vs. Cingulate Warrants | Black Diamond vs. SAB Biotherapeutics |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |